Xi Venture Capital has completed its lead investment in Weimai Medical's B+round financing

　　Recently, YOUMAGIC R&D company Weimai Medical completed a B+round financing of tens of millions of yuan. This round of financing is led by Xi Venture Capital and Suzhou Jinsheng Capital, and the funds will be used for continuous R&D investment of products, market channel expansion, brand building and other businesses.

　　Weimai Medical is the first high-end medical device enterprise in China to provide minimally invasive and non-invasive energy medicine solutions with energy ablation therapy systems as its technological core. It has achieved a product pipeline layout of "serious medical+consumer medical beauty". As a talent introduction enterprise of Wuxi Municipal Government, its YOUMAGIC technology team has partnered with Tsinghua University Wuxi Institute of Applied Technology to establish the "Energy Medicine Engineering Research Center".

　　Xi Venture Capital has long been deeply involved in strategic emerging industries such as biomedicine, actively exploring and cultivating potential projects, linking technological innovation and industrial development with capital strength, and continuously providing high-quality resources and service support for enterprises in technology research and development, market expansion, and other aspects.

　　　　　　　　　　　　　　About Weimai Medical

　　　　　　　　　　　　　　　　YOUMAGIC

　　It is reported that YOUMAGIC unipolar radiofrequency therapy device is the flagship product of Weimai Medical's layout in the consumer medical field. It relies on Tsinghua University's technology to achieve leadership and has innovative technological advantages such as 100 millisecond flash pulse technology, dynamic pulse technology, and multiple cooling. At present, including YOUMAGIC, multiple products of Weimai Medical have been approved for NMPA Class III certification, and their commercial layout is accelerating.